Quantum BioPharma Ltd (QNTM)

Currency in CAD
31.000
-3.180(-9.30%)
Closed·
QNTM Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
QNTM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
31.00034.500
52 wk Range
3.90052.000
Key Statistics
Bid/Ask
5.10 / 5.13
Prev. Close
5.07
Open
34
Day's Range
31-34.5
52 wk Range
3.9-52
Volume
2.26K
Average Volume (3m)
7.48K
1-Year Change
172.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
QNTM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Quantum BioPharma Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Quantum BioPharma Ltd Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.

Compare QNTM to Peers and Sector

Metrics to compare
QNTM
Peers
Sector
Relationship
P/E Ratio
−1.7x−1.5x−0.5x
PEG Ratio
-−0.010.00
Price/Book
6.3x0.7x2.6x
Price / LTM Sales
-1.9x3.2x
Upside (Analyst Target)
-45.5%42.0%
Fair Value Upside
Unlock16.2%6.6%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-3.47 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

QNTM Income Statement

FAQ

What Stock Exchange Does Quantum BioPharma Trade On?

Quantum BioPharma is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for Quantum BioPharma?

The stock symbol for Quantum BioPharma is "QNTM."

What Is the Quantum BioPharma Market Cap?

As of today, Quantum BioPharma market cap is 106.11M.

What Is Quantum BioPharma's Earnings Per Share (TTM)?

The Quantum BioPharma EPS (TTM) is -13.02.

From a Technical Analysis Perspective, Is QNTM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Quantum BioPharma Stock Split?

Quantum BioPharma has split 2 times.

How Many Employees Does Quantum BioPharma Have?

Quantum BioPharma has 17 employees.

What is the current trading status of Quantum BioPharma (QNTM)?

As of 30 Jul 2025, Quantum BioPharma (QNTM) is trading at a price of 31.00, with a previous close of 5.07. The stock has fluctuated within a day range of 31.00 to 34.50, while its 52-week range spans from 3.90 to 52.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.